You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 11, November 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  36TH ANNUAL SYMPOSIUM ON THE BIOLOGY OF SKIN
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ichthyosis Induced by Cholesterol-Lowering Drugs

Implications for Epidermal Cholesterol Homeostasis

Mary L. Williams, MD; Kenneth R. Feingold, MD; Gerhard Grubauer, MD; Peter M. Elias, MD

Arch Dermatol. 1987;123(11):1535-1538.


Abstract

• Ichthyosis and other disorders of cornification may occur as side effects of treatment with several hypocholesterolemic agents. Recent progress in understanding of the functional role of lipids in stratum corneum provides a new pathophysiologic basis for these earlier clinical observations. In stratum corneum, lipids are segregated within intercellular membranes, where they appear to regulate permeability barrier function and desquamation. Cholesterol is an important constituent of these membranes and may be essential to both of these functions. Perturbation of barrier function induces cholesterologenesis locally within the epidermis. Polar sterol metabolites, such as cholesterol sulfate, may also regulate epidermal sterologenesis under normal or pathologic circumstances. Cholesterol homeostasis may also modulate desquamation. For example, hairless mice fed azacosterol hydrochloride (20,25-diazacholesterol) develop a generalized scaling disorder without loss of barrier function. In these mice, total stratum corneum sterol content is markedly decreased, and topical or systemic repletion with cholesterol can correct the scaling abnormalities.

(Arch Dermatol 1987;123:1535-1538)



Author Affiliations

From the Departments of Dermatology (Drs Williams, Grubauer, and Elias), Pediatrics (Dr Williams), and Medicine (Dr Feingold), University of California School of Medicine, San Francisco, and the Dermatology (Drs Williams, Grubauer, and Elias) and Metabolism (Dr Feingold) Services, Veterans Administration Medical Center, San Francisco.


Footnotes

Accepted for publication June 5, 1987.

Read before the 36th Annual Symposium on the Biology of Skin ("Molecular Basis of Nutritional Dermatoses"), Salishan Lodge, Gleneden Beach, Ore, Oct 20, 1986.

Reprint requests to Dermatology Service (190), Veterans Administration Medical Center, 4150 Clement St, San Francisco, CA 94121 (Dr Williams).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

From Basket Weave to Barrier: Unifying Concepts for the Pathogenesis of the Disorders of Cornification
Williams and Elias
Arch Dermatol 1993;129:626-629.
ABSTRACT  

Exacerbation of Psoriasis by the Hypolipidemic Agent, Gemfibrozil
Fisher et al.
Arch Dermatol 1988;124:854-855.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.